A Study of LY3454738 in the Treatment of Adult Participants With Moderate-to-Severe Atopic Dermatitis
Clinical trial NCT05911841 · TERMINATED
Trial details
- NCT number
- NCT05911841
- Sponsor
- Eli Lilly and Company
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-21
- Primary completion
- 2024-10-10
- Enrollment
- 234
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.